Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

RFB4(dsFv)-PE38 recombinant immunotoxin × Other hematologic neoplasm × 30 days × Clear all

Sponsor

Interventions

venetoclax 92 Specimen Handling 56 Azacitidine 56 Cytarabine 49 Biopsy 45 Cyclophosphamide 41 fludarabine 32 Daunorubicin 24 Rituximab 23 Injections 21 Vincristine 19 Decitabine 19 Magnetic Resonance Spectroscopy 18 Prednisone 16 Methotrexate 16 ibrutinib 14 fludarabine phosphate 14 Granulocyte Colony-Stimulating Factor 14 Doxorubicin 14 CPX-351 13 obinutuzumab 12 Whole-Body Irradiation 12 Filgrastim 12 Stem Cell Transplantation 11 Idarubicin 11 Dexamethasone 11 blinatumomab 10 Melphalan 10 Etoposide 10 merphos 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡